Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Invest-CTO: Effectiveness and Safety of a Planned Investment Procedure in High-Risk CTO PCI

NCT04774913 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT04774913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04774913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Invest-CTO: Effectiveness and Safety of a Planned Investment Procedure in High-Risk CTO PCI
Lead sponsor
Haukeland University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 8, 2021
Completion date
October 31, 2026
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, chronic total occlusion of coronary artery, prom, quality of life